Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,374 public trials 412 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

NCT07565285

Conditions
Melanoma, Melanoma Stage III, Neoplasms, +10 more
Locations
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Gallipoli Medical Research Greenslopes, Queensland, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

NCT06246916

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 111 locations
View Trial Details
Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 229 locations
View Trial Details
Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

NCT06743126

Conditions
Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 71 locations
View Trial Details

Related conditions